Pre-Clinical (Discovery and Development)
Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
Keeping tabs on Covid-19: The rise and fall of the Russian-made vaccine
June 04 by Emily UwemedimoPending the review results from WHO and the EMA on Sputnik V, Russia hopes to squander its vaccine efficiency concerns
How an electronic lab notebook can accelerate time to market
June 02 by Pharma IQThis white paper from Biovia explores the benefits labs stand to gain by implementing an ELN solution
Keeping tabs on Covid-19: Asia lags in vaccine roll outs and new South Korean drug marked as a “game changer”
May 28 by Emily UwemedimoA “game changing” Covid-19 drug from South Korea has been introduced in a world-class academic journal
How to ensure your data journey is FAIR
May 26 by Pharma IQThis IDBS whitepaper addressed the concerns of life sciences organizations with poor access to data and how they can become better innovators
Keeping tabs on pharma: Covid-19 vaccine trials for children aged five to 11 proving effective and Oxford malaria vaccine commended for WHO-breakthrough
May 21 by Emily UwemedimoOxford malaria vaccine achieves high-level efficacy of 77 per cent in African children overcoming WHO’s specified efficacy goal of 75 per cent
Uncovering the hidden cost of inefficient laboratory practices
May 19 by Pharma IQMerck reveals how inventory management challenges directly impacts research outcomes, costs and regulatory compliance
Keeping tabs on Covid-19: Debate intensifies over Covid-19 vaccine patent waiver
May 14 by Emily UwemedimoChina and the US back vaccine waiver to help India’s Covid-19 crisis, while the UK and EU remain skeptical despite a willingness to discuss the proposal
Keeping tabs on Covid-19: India’s Covid-19 vaccine demand in crisis
April 30 by Emily UwemedimoThe US has dispatched 20 million AstraZeneca vaccine doses to India in an attempt to curb its second wave
Keeping tabs on Covid-19: AstraZeneca hoping to win US approval for their Covid-19 vaccine and J&J resumes its vaccine roll out in Europe
April 23 by Emily UwemedimoWith global demand for the Covid-19 vaccine still uncertain, two big pharma companies look to enhance their vaccination roll out programs in Europe and the US
What is the digital lab?
April 22 by Emily UwemedimoPharma IQ explores how to power pharma R&D and drug discovery using the digital lab featuring industry inside advice from the likes of Merck, Pfizer and Roche
Top tips for creating a culture of innovation to increase efficiency in the lab
April 08 by Pharma IQHear from two pharma experts from IDBS as they provide guidance for tackling key challenges affecting data management and research and development in the lab
Keeping tabs on Covid-19: Johnson & Johnson’s Covid-19 supply delay, Germany pauses its use of AstraZeneca’s vaccine and portable cold carrier launched to help with vaccine roll-out
April 01 by Emily UwemedimoThe European Medicines Agency sought to add clarity to the concerns surrounding AstraZeneca’s Covid-19 vaccine, but Germany has pressed the pause button as a “precaution” despite EMA backing